LYC Healthcare, which operates healthcare clinics and orthopedic surgery centers in Singapore, raised the proposed deal size for its upcoming IPO on Tuesday.
The Singapore-based company now plans to raise $25 million by offering 6.3 million shares at a proposed price of $4. The company had previously filed to offer 3 million shares at a price range of $4 to $6. At the revised deal size, LYC Healthcare will raise 67% more in proceeds than previously anticipated and command a market value of $137 million.
LYC Healthcare is a multidisciplinary specialist healthcare provider in Singapore offering an integrated suite of musculoskeletal services through two operating subsidiaries, five medical clinics and in-house advanced imaging facilities. It deploys four doctors, including two specialists, to deliver computer-navigated total hip and knee replacements, keyhole and minimally invasive procedures, alongside MRI, CT, X-ray, BMD and ultrasound imaging, and on-site physiotherapy via a three-year collaboration. The company treats patients with degenerative joint diseases, spine conditions, sports injuries, metabolic diseases and osteoporosis, providing care from health screenings and diagnostic scans to treatment and rehabilitation.
LYC Healthcare was founded in 2017 and booked $14 million in revenue for the 12 months ended March 31, 2025. It plans to list on the Nasdaq but has not yet chosen a ticker (RC ticker: LYCH.RC). Pacific Century Securities is the sole bookrunner on the deal, replacing AC Sunshine Securities.
